ACET Q1 2017 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$72M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$190M+20.4% YoY

Gross Profit

$42M22.3% margin

Operating Income

$13M6.9% margin

Net Income

$6M2.9% margin

EPS (Diluted)

$3.20

QoQ Revenue Growth

+51.4%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$656M

Stockholders' Equity

$402M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$190M	$158M	+20.4%
Gross Profit	$42M	$38M	+10.5%
Operating Income	$13M	$16M	-19.9%
Net Income	$6M	$10M	-46.4%

Revenue Segments

Human Health

$100M52%

Performance Chemicals

$46M24%

Pharmaceutical Ingredients

$44M23%